Hims & Hers Health, Inc. (HIMS) Tops Q2 EPS by 2c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Hims and Hers (HIMS) PT Lowered to $18 at Jefferies
August 7, 2024 10:16 AM EDTJefferies analyst Glen Santangelo lowered the price target on Hims and Hers (NYSE: HIMS) to $18.00 (from $23.00) while maintaining a Hold rating.
The analyst comments "We are updating our model following 2Q results and management's initial commentary on GLP-1s. We are raising our revenue... More
Hims and Hers (HIMS) PT Raised to $23 at Deutsche Bank
August 6, 2024 4:22 PM EDTDeutsche Bank analyst George Hill raised the price target on Hims and Hers (NYSE: HIMS) to $23.00 (from $16.00) while maintaining a Hold rating.
The analyst comments "Positioned to Grow Specialty Platform: HIMS reported a Q2 beat on a broad basis AMC on Monday where the GLP-1 opportunity in the near term was the overwhelming focus of the earnings call. Since the company... More
